FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to pediatrics, and is intended to assess the risk of severe physiological jaundice in newborns. The level of erythrocyte magnesium (mmol/l) and the level of matrix metalloproteinase IX (ng/ml) in the blood serum is determined. The study is carried out twice - immediately after the birth of the child and 4 days after birth, the ratio of the level of magnesium of erythrocytes to the level of matrix metalloproteinase IX is calculated. With a decrease in this ratio in dynamics for two studies by at least 20%, a high risk of severe physiological jaundice of newborns is revealed. Otherwise, the risk of developing severe physiological jaundice in newborns is negligible.
EFFECT: invention provides reliable detection of newborns with a high risk of severe physiological jaundice.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR CONNECTIVE TISSUE DYSPLASIA IN NEWBORNS | 2020 |
|
RU2741699C1 |
| METHOD FOR ASSESSMENT OF RISK OF REDUCTION IN HEALTH LEVEL IN CHILDREN OF FIRST YEAR OF LIFE | 2021 |
|
RU2783674C1 |
| METHOD FOR PREVENTIVE DIAGNOSIS OF THE RISK OF REDUCING THE LEVEL OF HEALTH OF ADOLESCENT GIRLS | 2021 |
|
RU2782556C1 |
| METHOD OF PREDICTING DEVELOPMENT OF EARLY NEONATAL SEPSIS IN NEWBORNS WHOSE MOTHERS HAD COVID-19 DURING PREGNANCY | 2023 |
|
RU2813809C1 |
| METHOD FOR PREDICTING PROGRESS OF ADAPTATION IN NEONATES | 1991 |
|
RU2009510C1 |
| METHOD OF TREATING CONJUGATION HYPERBILIRUBINEMIA IN INFANTS | 2014 |
|
RU2570479C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF HYPERBILIRUBINEMIA IN FULL-TERM NEWBORNS BORN BY THE CESAREAN SECTION OPERATION METHOD | 2019 |
|
RU2711107C1 |
| METHOD FOR ASSESSING THE RISK OF NEUROLOGICAL COMPLICATIONS IN PATIENTS WITH BLOOD DISEASES | 2019 |
|
RU2696780C1 |
| METHOD OF TREATMENT OF HYPERBILIRUBINEMIA IN NEWBORNS | 0 |
|
SU1806604A1 |
| METHOD FOR TREATING HYPERBILIRUBINEMIAE IN NEWBORN INFANTS | 1994 |
|
RU2095098C1 |
